PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"22397651","Donepezil and memantine for moderate-to-severe Alzheimer's disease","Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T, Findlay D, Holmes C, Hughes A, Jacoby R, Jones R, Jones R, McKeith I, Macharouthu A, O'Brien J, Passmore P, Sheehan B, Juszczak E, Katona C, Hills R, Knapp M, Ballard C, Brown R, Banerjee S, Onions C, Griffin M, Adams J, Gray R, Johnson T, Bentham P, Phillips P.","N Engl J Med. 2012 Mar 8;366(10):893-903. doi: 10.1056/NEJMoa1106668.","Howard R","N Engl J Med","2012","2012/03/09","","","10.1056/NEJMoa1106668"
"27739182","Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial)","Knapp M, King D, Romeo R, Adams J, Baldwin A, Ballard C, Banerjee S, Barber R, Bentham P, Brown RG, Burns A, Dening T, Findlay D, Holmes C, Johnson T, Jones R, Katona C, Lindesay J, Macharouthu A, McKeith I, McShane R, O'Brien JT, Phillips PPJ, Sheehan B, Howard R.","Int J Geriatr Psychiatry. 2017 Dec;32(12):1205-1216. doi: 10.1002/gps.4583. Epub 2016 Oct 13.","Knapp M","Int J Geriatr Psychiatry","2017","2016/10/15","PMC5724694","","10.1002/gps.4583"
"32463470","Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial","Maier F, Spottke A, Bach JP, Bartels C, Buerger K, Dodel R, Fellgiebel A, Fliessbach K, Frölich L, Hausner L, Hellmich M, Klöppel S, Klostermann A, Kornhuber J, Laske C, Peters O, Priller J, Richter-Schmidinger T, Schneider A, Shah-Hosseini K, Teipel S, von Arnim CAF, Wiltfang J, Jessen F.","JAMA Netw Open. 2020 May 1;3(5):e206027. doi: 10.1001/jamanetworkopen.2020.6027.","Maier F","JAMA Netw Open","2020","2020/05/29","PMC7256670","","10.1001/jamanetworkopen.2020.6027"
"20872778","SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study","Maher-Edwards G, Dixon R, Hunter J, Gold M, Hopton G, Jacobs G, Hunter J, Williams P.","Int J Geriatr Psychiatry. 2011 May;26(5):536-44. doi: 10.1002/gps.2562. Epub 2010 Sep 24.","Maher-Edwards G","Int J Geriatr Psychiatry","2011","2010/09/28","","","10.1002/gps.2562"
"26402762","APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer's Disease","Waring JF, Tang Q, Robieson WZ, King DP, Das U, Dubow J, Dutta S, Marek GJ, Gault LM.","J Alzheimers Dis. 2015;47(1):137-48. doi: 10.3233/JAD-142589.","Waring JF","J Alzheimers Dis","2015","2015/09/25","PMC4923746","","10.3233/JAD-142589"
"22915447","Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study","Dubois B, Tolosa E, Katzenschlager R, Emre M, Lees AJ, Schumann G, Pourcher E, Gray J, Thomas G, Swartz J, Hsu T, Moline ML.","Mov Disord. 2012 Sep 1;27(10):1230-8. doi: 10.1002/mds.25098. Epub 2012 Aug 22.","Dubois B","Mov Disord","2012","2012/08/24","","","10.1002/mds.25098"
"18198262","Donepezil improves obstructive sleep apnea in Alzheimer disease: a double-blind, placebo-controlled study","Moraes W, Poyares D, Sukys-Claudino L, Guilleminault C, Tufik S.","Chest. 2008 Mar;133(3):677-83. doi: 10.1378/chest.07-1446. Epub 2008 Jan 15.","Moraes W","Chest","2008","2008/01/17","","","10.1378/chest.07-1446"
"17664405","Donepezil preserves cognition and global function in patients with severe Alzheimer disease","Black SE, Doody R, Li H, McRae T, Jambor KM, Xu Y, Sun Y, Perdomo CA, Richardson S.","Neurology. 2007 Jul 31;69(5):459-69. doi: 10.1212/01.wnl.0000266627.96040.5a.","Black SE","Neurology","2007","2007/08/01","","","10.1212/01.wnl.0000266627.96040.5a"
"26923256","Donepezil 23 mg in Asian patients with moderate-to-severe Alzheimer's disease","Han SH, Lee JH, Kim SY, Park KW, Chen C, Tripathi M, Dash A, Kubota N.","Acta Neurol Scand. 2017 Feb;135(2):252-256. doi: 10.1111/ane.12571. Epub 2016 Feb 29.","Han SH","Acta Neurol Scand","2017","2016/03/01","","","10.1111/ane.12571"
"28157100","Efficacy and Safety of Donepezil in Chinese Patients with Severe Alzheimer's Disease: A Randomized Controlled Trial","Jia J, Wei C, Jia L, Tang Y, Liang J, Zhou A, Li F, Shi L, Doody RS.","J Alzheimers Dis. 2017;56(4):1495-1504. doi: 10.3233/JAD-161117.","Jia J","J Alzheimers Dis","2017","2017/02/04","","","10.3233/JAD-161117"
"16581404","Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study","Winblad B, Kilander L, Eriksson S, Minthon L, Båtsman S, Wetterholm AL, Jansson-Blixt C, Haglund A; Severe Alzheimer's Disease Study Group.","Lancet. 2006 Apr 1;367(9516):1057-1065. doi: 10.1016/S0140-6736(06)68350-5.","Winblad B","Lancet","2006","2006/04/04","","","10.1016/S0140-6736(06)68350-5"
"17914039","Donepezil for the treatment of agitation in Alzheimer's disease","Howard RJ, Juszczak E, Ballard CG, Bentham P, Brown RG, Bullock R, Burns AS, Holmes C, Jacoby R, Johnson T, Knapp M, Lindesay J, O'Brien JT, Wilcock G, Katona C, Jones RW, DeCesare J, Rodger M; CALM-AD Trial Group.","N Engl J Med. 2007 Oct 4;357(14):1382-92. doi: 10.1056/NEJMoa066583.","Howard RJ","N Engl J Med","2007","2007/10/05","","","10.1056/NEJMoa066583"
"25596420","Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease","Dubois B, Chupin M, Hampel H, Lista S, Cavedo E, Croisile B, Louis Tisserand G, Touchon J, Bonafe A, Ousset PJ, Ait Ameur A, Rouaud O, Ricolfi F, Vighetto A, Pasquier F, Delmaire C, Ceccaldi M, Girard N, Dufouil C, Lehericy S, Tonelli I, Duveau F, Colliot O, Garnero L, Sarazin M, Dormont D; “Hippocampus Study Group”; Hippocampus Study Group.","Alzheimers Dement. 2015 Sep;11(9):1041-9. doi: 10.1016/j.jalz.2014.10.003. Epub 2015 Jan 14.","Dubois B","Alzheimers Dement","2015","2015/01/18","","","10.1016/j.jalz.2014.10.003"
"16083542","Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period","Bullock R, Touchon J, Bergman H, Gambina G, He Y, Rapatz G, Nagel J, Lane R.","Curr Med Res Opin. 2005 Aug;21(8):1317-27. doi: 10.1185/030079905X56565.","Bullock R","Curr Med Res Opin","2005","2005/08/09","","","10.1185/030079905X56565"
"31498121","A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Teprenone in Patients with Alzheimer's Disease","Yokoyama S, Yoshinaga T, Matsuzaki J, Suzuki H.","J Alzheimers Dis. 2019;71(4):1187-1199. doi: 10.3233/JAD-190305.","Yokoyama S","J Alzheimers Dis","2019","2019/09/10","","","10.3233/JAD-190305"
"12442882","Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer's disease","Gauthier S, Feldman H, Hecker J, Vellas B, Emir B, Subbiah P; Donepezil MSAD Study Investigators' Group.","Curr Med Res Opin. 2002;18(6):347-54. doi: 10.1185/030079902125001029.","Gauthier S","Curr Med Res Opin","2002","2002/11/22","","","10.1185/030079902125001029"
"15965198","Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study","Ravina B, Putt M, Siderowf A, Farrar JT, Gillespie M, Crawley A, Fernandez HH, Trieschmann MM, Reichwein S, Simuni T.","J Neurol Neurosurg Psychiatry. 2005 Jul;76(7):934-9. doi: 10.1136/jnnp.2004.050682.","Ravina B","J Neurol Neurosurg Psychiatry","2005","2005/06/21","PMC1739697","","10.1136/jnnp.2004.050682"
"21335973","A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's disease","Burns A, Perry E, Holmes C, Francis P, Morris J, Howes MJ, Chazot P, Lees G, Ballard C.","Dement Geriatr Cogn Disord. 2011;31(2):158-64. doi: 10.1159/000324438. Epub 2011 Feb 19.","Burns A","Dement Geriatr Cogn Disord","2011","2011/02/22","","","10.1159/000324438"
"22281004","Beneficial effect of donepezil on obstructive sleep apnea: a double-blind, placebo-controlled clinical trial","Sukys-Claudino L, Moraes W, Guilleminault C, Tufik S, Poyares D.","Sleep Med. 2012 Mar;13(3):290-6. doi: 10.1016/j.sleep.2011.09.014. Epub 2012 Jan 26.","Sukys-Claudino L","Sleep Med","2012","2012/01/28","","","10.1016/j.sleep.2011.09.014"
"15596605","Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial","Seltzer B, Zolnouni P, Nunez M, Goldman R, Kumar D, Ieni J, Richardson S; Donepezil ""402"" Study Group.","Arch Neurol. 2004 Dec;61(12):1852-6. doi: 10.1001/archneur.61.12.1852.","Seltzer B","Arch Neurol","2004","2004/12/15","","","10.1001/archneur.61.12.1852"
"30565793","Donepezil for gait and falls in mild cognitive impairment: a randomized controlled trial","Montero-Odasso M, Speechley M, Chertkow H, Sarquis-Adamson Y, Wells J, Borrie M, Vanderhaeghe L, Zou GY, Fraser S, Bherer L, Muir-Hunter SW.","Eur J Neurol. 2019 Apr;26(4):651-659. doi: 10.1111/ene.13872. Epub 2018 Dec 26.","Montero-Odasso M","Eur J Neurol","2019","2018/12/20","","","10.1111/ene.13872"
"11921156","A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease--pilot study","Prasher VP, Huxley A, Haque MS; Down syndrome Ageing Study Group.","Int J Geriatr Psychiatry. 2002 Mar;17(3):270-8. doi: 10.1002/gps.587.","Prasher VP","Int J Geriatr Psychiatry","2002","2002/03/29","","","10.1002/gps.587"
"10325453","The effects of donepezil in Alzheimer's disease - results from a multinational trial","Burns A, Rossor M, Hecker J, Gauthier S, Petit H, Möller HJ, Rogers SL, Friedhoff LT.","Dement Geriatr Cogn Disord. 1999 May-Jun;10(3):237-44. doi: 10.1159/000017126.","Burns A","Dement Geriatr Cogn Disord","1999","1999/05/15","","","10.1159/000017126"
"21679156","Combination treatment in Alzheimer's disease: results of a randomized, controlled trial with cerebrolysin and donepezil","Alvarez XA, Cacabelos R, Sampedro C, Couceiro V, Aleixandre M, Vargas M, Linares C, Granizo E, García-Fantini M, Baurecht W, Doppler E, Moessler H.","Curr Alzheimer Res. 2011 Aug;8(5):583-91. doi: 10.2174/156720511796391863.","Alvarez XA","Curr Alzheimer Res","2011","2011/06/18","","","10.2174/156720511796391863"
"11290880","Donepezil, rivastigmine, and vitamin E in Alzheimer disease: a combined P300 event-related potentials/neuropsychologic evaluation over 6 months","Thomas A, Iacono D, Bonanni L, D'Andreamatteo G, Onofrj M.","Clin Neuropharmacol. 2001 Jan-Feb;24(1):31-42. doi: 10.1097/00002826-200101000-00007.","Thomas A","Clin Neuropharmacol","2001","2001/04/06","","","10.1097/00002826-200101000-00007"
"16508298","3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy","Winblad B, Wimo A, Engedal K, Soininen H, Verhey F, Waldemar G, Wetterholm AL, Haglund A, Zhang R, Schindler R.","Dement Geriatr Cogn Disord. 2006;21(5-6):353-63. doi: 10.1159/000091790. Epub 2006 Feb 27.","Winblad B","Dement Geriatr Cogn Disord","2006","2006/03/02","","","10.1159/000091790"
"29635383","Attention Measures of Accuracy, Variability, and Fatigue Detect Early Response to Donepezil in Alzheimer's Disease: A Randomized, Double-blind, Placebo-Controlled Pilot Trial","Vila-Castelar C, Ly JJ, Kaplan L, Van Dyk K, Berger JT, Macina LO, Stewart JL, Foldi NS.","Arch Clin Neuropsychol. 2019 May 1;34(3):277-289. doi: 10.1093/arclin/acy032.","Vila-Castelar C","Arch Clin Neuropsychol","2019","2018/04/11","PMC6487534","","10.1093/arclin/acy032"
"26967222","Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer's Disease: A Randomized, Double-Blind Trial","Homma A, Atarashi H, Kubota N, Nakai K, Takase T.","J Alzheimers Dis. 2016 Mar 11;52(1):345-57. doi: 10.3233/JAD-151149.","Homma A","J Alzheimers Dis","2016","2016/03/12","","","10.3233/JAD-151149"
"20597141","Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease","Waldemar G, Gauthier S, Jones R, Wilkinson D, Cummings J, Lopez O, Zhang R, Xu Y, Sun Y, Knox S, Richardson S, Mackell J.","Int J Geriatr Psychiatry. 2011 Feb;26(2):150-7. doi: 10.1002/gps.2507.","Waldemar G","Int J Geriatr Psychiatry","2011","2010/07/03","","","10.1002/gps.2507"
"20634594","Effect of donepezil on cognition in severe Alzheimer's disease: a pooled data analysis","Cummings J, Jones R, Wilkinson D, Lopez O, Gauthier S, Waldemar G, Zhang R, Xu Y, Sun Y, Richardson S, Mackell J.","J Alzheimers Dis. 2010;21(3):843-51. doi: 10.3233/JAD-2010-100078.","Cummings J","J Alzheimers Dis","2010","2010/07/17","","","10.3233/JAD-2010-100078"
"24315979","Donepezil treatment of older adults with cognitive impairment and depression (DOTCODE study): clinical rationale and design","Pelton GH, Andrews H, Roose SP, Marcus SM, D'Antonio K, Husn H, Petrella JR, Zannas AS, Doraiswamy PM, Devanand DP.","Contemp Clin Trials. 2014 Mar;37(2):200-8. doi: 10.1016/j.cct.2013.11.015. Epub 2013 Dec 5.","Pelton GH","Contemp Clin Trials","2014","2013/12/10","PMC3981878","NIHMS546528","10.1016/j.cct.2013.11.015"
"16494088","The effect of donepezil on sleep and REM sleep EEG in patients with Alzheimer disease: a double-blind placebo-controlled study","Moraes Wdos S, Poyares DR, Guilleminault C, Ramos LR, Bertolucci PH, Tufik S.","Sleep. 2006 Feb;29(2):199-205. doi: 10.1093/sleep/29.2.199.","Moraes Wdos S","Sleep","2006","2006/02/24","","","10.1093/sleep/29.2.199"
"9588436","Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group","Rogers SL, Doody RS, Mohs RC, Friedhoff LT.","Arch Intern Med. 1998 May 11;158(9):1021-31. doi: 10.1001/archinte.158.9.1021.","Rogers SL","Arch Intern Med","1998","1998/05/20","","","10.1001/archinte.158.9.1021"
"19623601","The long-term efficacy and tolerability of donepezil in patients with vascular dementia","Wilkinson D, Róman G, Salloway S, Hecker J, Boundy K, Kumar D, Posner H, Schindler R.","Int J Geriatr Psychiatry. 2010 Mar;25(3):305-13. doi: 10.1002/gps.2340.","Wilkinson D","Int J Geriatr Psychiatry","2010","2009/07/23","","","10.1002/gps.2340"
"30109588","Effect and Safety of Huannao Yicong Formula () in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Double-Blinded, Donepezil-Controlled Trial","Yang Y, Liu JP, Fang JY, Wang HC, Wei Y, Cao Y, Liu JG, Liu LT, Li H.","Chin J Integr Med. 2019 Aug;25(8):574-581. doi: 10.1007/s11655-018-3054-7. Epub 2018 Aug 14.","Yang Y","Chin J Integr Med","2019","2018/08/16","","","10.1007/s11655-018-3054-7"
"19246907","Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan","Homma A, Imai Y, Tago H, Asada T, Shigeta M, Iwamoto T, Takita M, Arimoto I, Koma H, Takase T, Ohbayashi T.","Dement Geriatr Cogn Disord. 2009;27(3):232-9. doi: 10.1159/000203887. Epub 2009 Feb 25.","Homma A","Dement Geriatr Cogn Disord","2009","2009/02/28","","","10.1159/000203887"
"11843990","A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting","Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.","J Am Geriatr Soc. 2001 Dec;49(12):1590-9.","Tariot PN","J Am Geriatr Soc","2001","2002/02/15","","",""
"11524468","A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease","Feldman H, Gauthier S, Hecker J, Vellas B, Subbiah P, Whalen E; Donepezil MSAD Study Investigators Group.","Neurology. 2001 Aug 28;57(4):613-20. doi: 10.1212/wnl.57.4.613.","Feldman H","Neurology","2001","2001/08/29","","","10.1212/wnl.57.4.613"
"28035924","The Effect of the Association between Donepezil and Choline Alphoscerate on Behavioral Disturbances in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial","Carotenuto A, Rea R, Traini E, Fasanaro AM, Ricci G, Manzo V, Amenta F.","J Alzheimers Dis. 2017;56(2):805-815. doi: 10.3233/JAD-160675.","Carotenuto A","J Alzheimers Dis","2017","2016/12/31","","","10.3233/JAD-160675"
"8915035","The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group","Rogers SL, Friedhoff LT.","Dementia. 1996 Nov-Dec;7(6):293-303. doi: 10.1159/000106895.","Rogers SL","Dementia","1996","1996/11/01","","","10.1159/000106895"
"18296124","Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL","Dichgans M, Markus HS, Salloway S, Verkkoniemi A, Moline M, Wang Q, Posner H, Chabriat HS.","Lancet Neurol. 2008 Apr;7(4):310-8. doi: 10.1016/S1474-4422(08)70046-2. Epub 2008 Feb 28.","Dichgans M","Lancet Neurol","2008","2008/02/26","","","10.1016/S1474-4422(08)70046-2"
"24418055","Efficacy and safety evaluation of HSD-1 inhibitor ABT-384 in Alzheimer's disease","Marek GJ, Katz DA, Meier A, Greco N 4th, Zhang W, Liu W, Lenz RA.","Alzheimers Dement. 2014 Oct;10(5 Suppl):S364-73. doi: 10.1016/j.jalz.2013.09.010. Epub 2014 Jan 10.","Marek GJ","Alzheimers Dement","2014","2014/01/15","","","10.1016/j.jalz.2013.09.010"
"15220031","Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial","Courtney C, Farrell D, Gray R, Hills R, Lynch L, Sellwood E, Edwards S, Hardyman W, Raftery J, Crome P, Lendon C, Shaw H, Bentham P; AD2000 Collaborative Group.","Lancet. 2004 Jun 26;363(9427):2105-15. doi: 10.1016/S0140-6736(04)16499-4.","Courtney C","Lancet","2004","2004/06/29","","","10.1016/S0140-6736(04)16499-4"
"16327351","Effects of galantamine versus donepezil on sleep in patients with mild to moderate Alzheimer disease and their caregivers: a double-blind, head-to-head, randomized pilot study","Ancoli-Israel S, Amatniek J, Ascher S, Sadik K, Ramaswamy K.","Alzheimer Dis Assoc Disord. 2005 Oct-Dec;19(4):240-5. doi: 10.1097/01.wad.0000189052.48688.36.","Ancoli-Israel S","Alzheimer Dis Assoc Disord","2005","2005/12/06","","","10.1097/01.wad.0000189052.48688.36"
"18257603","Safety and tolerability of donepezil at doses up to 20 mg/day: results from a pilot study in patients with Alzheimer's disease","Doody RS, Corey-Bloom J, Zhang R, Li H, Ieni J, Schindler R.","Drugs Aging. 2008;25(2):163-74. doi: 10.2165/00002512-200825020-00008.","Doody RS","Drugs Aging","2008","2008/02/09","","","10.2165/00002512-200825020-00008"
"27756421","ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension","Gault LM, Lenz RA, Ritchie CW, Meier A, Othman AA, Tang Q, Berry S, Pritchett Y, Robieson WZ.","Alzheimers Res Ther. 2016 Oct 18;8(1):44. doi: 10.1186/s13195-016-0210-1.","Gault LM","Alzheimers Res Ther","2016","2016/10/21","PMC5067903","","10.1186/s13195-016-0210-1"
"27567841","Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects","De Beaumont L, Pelleieux S, Lamarre-Théroux L, Dea D, Poirier J; Alzheimer’s Disease Cooperative Study.","J Alzheimers Dis. 2016 Oct 4;54(3):913-922. doi: 10.3233/JAD-160373.","De Beaumont L","J Alzheimers Dis","2016","2016/08/29","","","10.3233/JAD-160373"
"22813231","The effect of stimulation therapy and donepezil on cognitive function in Alzheimer's disease. A community based RCT with a two-by-two factorial design","Andersen F, Viitanen M, Halvorsen DS, Straume B, Wilsgaard T, Engstad TA.","BMC Neurol. 2012 Jul 19;12:59. doi: 10.1186/1471-2377-12-59.","Andersen F","BMC Neurol","2012","2012/07/21","PMC3481364","","10.1186/1471-2377-12-59"
"10793322","Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study","Rogers SL, Doody RS, Pratt RD, Ieni JR.","Eur Neuropsychopharmacol. 2000 May;10(3):195-203. doi: 10.1016/s0924-977x(00)00067-5.","Rogers SL","Eur Neuropsychopharmacol","2000","2000/05/04","","","10.1016/s0924-977x(00)00067-5"
"15920715","Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial","Feldman H, Gauthier S, Hecker J, Vellas B, Xu Y, Ieni JR, Schwam EM; Donepezil MSAD Study Investigators Group.","Int J Geriatr Psychiatry. 2005 Jun;20(6):559-69. doi: 10.1002/gps.1325.","Feldman H","Int J Geriatr Psychiatry","2005","2005/05/28","","","10.1002/gps.1325"
"26402001","Apathy Treatment in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial","Rea R, Carotenuto A, Traini E, Fasanaro AM, Manzo V, Amenta F.","J Alzheimers Dis. 2015;48(2):377-83. doi: 10.3233/JAD-141983.","Rea R","J Alzheimers Dis","2015","2015/09/25","","","10.3233/JAD-141983"
"29716655","A double-blind placebo-controlled cross-over clinical trial of DONepezil In Posterior cortical atrophy due to underlying Alzheimer's Disease: DONIPAD study","Ridha BH, Crutch S, Cutler D, Frost C, Knight W, Barker S, Epie N, Warrington EK, Kukkastenvehmas R, Douglas J, Rossor MN.","Alzheimers Res Ther. 2018 May 1;10(1):44. doi: 10.1186/s13195-018-0363-1.","Ridha BH","Alzheimers Res Ther","2018","2018/05/03","PMC5930935","","10.1186/s13195-018-0363-1"
"20224285","Treatment of Alzheimer's disease with a cholinesterase inhibitor combined with antioxidants","Cornelli U.","Neurodegener Dis. 2010;7(1-3):193-202. doi: 10.1159/000295663. Epub 2010 Mar 12.","Cornelli U","Neurodegener Dis","2010","2010/03/13","","","10.1159/000295663"
"11044775","Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group","Homma A, Takeda M, Imai Y, Udaka F, Hasegawa K, Kameyama M, Nishimura T.","Dement Geriatr Cogn Disord. 2000 Nov-Dec;11(6):299-313. doi: 10.1159/000017259.","Homma A","Dement Geriatr Cogn Disord","2000","2000/10/25","","","10.1159/000017259"
"23742728","Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: analysis of effects of baseline features on treatment response","Sabbagh M, Cummings J, Christensen D, Doody R, Farlow M, Liu L, Mackell J, Fain R.","BMC Geriatr. 2013 Jun 6;13:56. doi: 10.1186/1471-2318-13-56.","Sabbagh M","BMC Geriatr","2013","2013/06/08","PMC3681558","","10.1186/1471-2318-13-56"
"19606472","The efficacy, safety, and tolerability of donepezil for the treatment of young adults with Down syndrome","Kishnani PS, Sommer BR, Handen BL, Seltzer B, Capone GT, Spiridigliozzi GA, Heller JH, Richardson S, McRae T.","Am J Med Genet A. 2009 Aug;149A(8):1641-54. doi: 10.1002/ajmg.a.32953.","Kishnani PS","Am J Med Genet A","2009","2009/07/17","","","10.1002/ajmg.a.32953"
"16832078","Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment","Cummings JL, Schneider E, Tariot PN, Graham SM; Memantine MEM-MD-02 Study Group.","Neurology. 2006 Jul 11;67(1):57-63. doi: 10.1212/01.wnl.0000223333.42368.f1.","Cummings JL","Neurology","2006","2006/07/13","","","10.1212/01.wnl.0000223333.42368.f1"
"16930364","Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study","Mazza M, Capuano A, Bria P, Mazza S.","Eur J Neurol. 2006 Sep;13(9):981-5. doi: 10.1111/j.1468-1331.2006.01409.x.","Mazza M","Eur J Neurol","2006","2006/08/26","","","10.1111/j.1468-1331.2006.01409.x"
"17600848","A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease","Connelly PJ, Prentice NP, Cousland G, Bonham J.","Int J Geriatr Psychiatry. 2008 Feb;23(2):155-60. doi: 10.1002/gps.1856.","Connelly PJ","Int J Geriatr Psychiatry","2008","2007/06/30","","","10.1002/gps.1856"
"22572767","Efficacy and safety of donepezil 23 mg versus donepezil 10 mg for moderate-to-severe Alzheimer's disease: a subgroup analysis in patients already taking or not taking concomitant memantine","Doody RS, Geldmacher DS, Farlow MR, Sun Y, Moline M, Mackell J.","Dement Geriatr Cogn Disord. 2012;33(2-3):164-73. doi: 10.1159/000338236. Epub 2012 May 10.","Doody RS","Dement Geriatr Cogn Disord","2012","2012/05/11","","","10.1159/000338236"
"22959283","The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results","Amenta F, Carotenuto A, Fasanaro AM, Rea R, Traini E.","J Neurol Sci. 2012 Nov 15;322(1-2):96-101. doi: 10.1016/j.jns.2012.07.003. Epub 2012 Sep 7.","Amenta F","J Neurol Sci","2012","2012/09/11","","","10.1016/j.jns.2012.07.003"
"9443470","A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group","Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT.","Neurology. 1998 Jan;50(1):136-45. doi: 10.1212/wnl.50.1.136.","Rogers SL","Neurology","1998","1998/01/27","","","10.1212/wnl.50.1.136"
"26515660","Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses","Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T, Findlay D, Holmes C, Jones R, Jones R, McKeith I, Macharouthu A, O'Brien J, Sheehan B, Juszczak E, Katona C, Hills R, Knapp M, Ballard C, Brown RG, Banerjee S, Adams J, Johnson T, Bentham P, Phillips PP.","Lancet Neurol. 2015 Dec;14(12):1171-81. doi: 10.1016/S1474-4422(15)00258-6. Epub 2015 Oct 27.","Howard R","Lancet Neurol","2015","2015/10/31","","","10.1016/S1474-4422(15)00258-6"
"9452942","Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study","Rogers SL, Friedhoff LT.","Eur Neuropsychopharmacol. 1998 Feb;8(1):67-75. doi: 10.1016/s0924-977x(97)00079-5.","Rogers SL","Eur Neuropsychopharmacol","1998","1998/02/07","","","10.1016/s0924-977x(97)00079-5"
"12151908","Donepezil versus vitamin E in Alzheimer's disease: Part 2: mild versus moderate-severe Alzheimer's disease","Onofrj M, Thomas A, Luciano AL, Iacono D, Di Rollo A, D'Andreamatteo G, Di Iorio A.","Clin Neuropharmacol. 2002 Jul-Aug;25(4):207-15. doi: 10.1097/00002826-200207000-00004.","Onofrj M","Clin Neuropharmacol","2002","2002/08/02","","","10.1097/00002826-200207000-00004"
"17627484","Does the cholinesterase inhibitor, donepezil, benefit both declarative and non-declarative processes in mild to moderate Alzheimer's disease?","Winstein CJ, Bentzen KR, Boyd L, Schneider LS.","Curr Alzheimer Res. 2007 Jul;4(3):273-6. doi: 10.2174/156720507781077296.","Winstein CJ","Curr Alzheimer Res","2007","2007/07/14","","","10.2174/156720507781077296"
"24898643","The ASCOMALVA (Association between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in Alzheimer's Disease) Trial: interim results after two years of treatment","Amenta F, Carotenuto A, Fasanaro AM, Rea R, Traini E.","J Alzheimers Dis. 2014;42 Suppl 3:S281-8. doi: 10.3233/JAD-140150.","Amenta F","J Alzheimers Dis","2014","2014/06/06","","","10.3233/JAD-140150"
"16599649","Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's disease","Johannsen P, Salmon E, Hampel H, Xu Y, Richardson S, Qvitzau S, Schindler R; AWARE Study Group.","CNS Drugs. 2006;20(4):311-25. doi: 10.2165/00023210-200620040-00005.","Johannsen P","CNS Drugs","2006","2006/04/08","","","10.2165/00023210-200620040-00005"
"19347685","Ginkgo biloba extract EGb 761(R), donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: a randomised, double-blind, exploratory trial","Yancheva S, Ihl R, Nikolova G, Panayotov P, Schlaefke S, Hoerr R; GINDON Study Group.","Aging Ment Health. 2009 Mar;13(2):183-90. doi: 10.1080/13607860902749057.","Yancheva S","Aging Ment Health","2009","2009/04/07","","","10.1080/13607860902749057"
"14594748","Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease","Krishnan KR, Charles HC, Doraiswamy PM, Mintzer J, Weisler R, Yu X, Perdomo C, Ieni JR, Rogers S.","Am J Psychiatry. 2003 Nov;160(11):2003-11. doi: 10.1176/appi.ajp.160.11.2003.","Krishnan KR","Am J Psychiatry","2003","2003/11/05","","","10.1176/appi.ajp.160.11.2003"
"14716694","A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil","Finkel SI, Mintzer JE, Dysken M, Krishnan KR, Burt T, McRae T.","Int J Geriatr Psychiatry. 2004 Jan;19(1):9-18. doi: 10.1002/gps.998.","Finkel SI","Int J Geriatr Psychiatry","2004","2004/01/13","","","10.1002/gps.998"
"17199235","Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease","Burns A, Gauthier S, Perdomo C.","Int J Geriatr Psychiatry. 2007 Aug;22(8):806-12. doi: 10.1002/gps.1746.","Burns A","Int J Geriatr Psychiatry","2007","2007/01/03","","","10.1002/gps.1746"
"18300284","Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease","Kadir A, Andreasen N, Almkvist O, Wall A, Forsberg A, Engler H, Hagman G, Lärksäter M, Winblad B, Zetterberg H, Blennow K, Långström B, Nordberg A.","Ann Neurol. 2008 May;63(5):621-31. doi: 10.1002/ana.21345.","Kadir A","Ann Neurol","2008","2008/02/27","","","10.1002/ana.21345"
"12834513","Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease","Geldmacher DS, Provenzano G, McRae T, Mastey V, Ieni JR.","J Am Geriatr Soc. 2003 Jul;51(7):937-44. doi: 10.1046/j.1365-2389.2003.51306.x.","Geldmacher DS","J Am Geriatr Soc","2003","2003/07/02","","","10.1046/j.1365-2389.2003.51306.x"
"30761509","Efficacy of Cilostazol Administration in Alzheimer's Disease Patients with White Matter Lesions: A Positron-Emission Tomography Study","Lee JY, Lee H, Yoo HB, Choi JS, Jung HY, Yoon EJ, Kim H, Jung YH, Lee HY, Kim YK.","Neurotherapeutics. 2019 Apr;16(2):394-403. doi: 10.1007/s13311-018-00708-x.","Lee JY","Neurotherapeutics","2019","2019/02/15","PMC6554387","","10.1007/s13311-018-00708-x"
"26297124","Combined therapy of Di-Huang-Yi-Zhi with Donepezil in patients with Parkinson's disease dementia","Gu C, Shen T, An H, Yuan C, Zhou J, Ye Q, Liu T, Wang X, Zhang T.","Neurosci Lett. 2015 Oct 8;606:13-7. doi: 10.1016/j.neulet.2015.08.019. Epub 2015 Aug 18.","Gu C","Neurosci Lett","2015","2015/08/23","","","10.1016/j.neulet.2015.08.019"
"19528519","Donepezil delays progression to AD in MCI subjects with depressive symptoms","Lu PH, Edland SD, Teng E, Tingus K, Petersen RC, Cummings JL; Alzheimer's Disease Cooperative Study Group.","Neurology. 2009 Jun 16;72(24):2115-21. doi: 10.1212/WNL.0b013e3181aa52d3.","Lu PH","Neurology","2009","2009/06/17","PMC2697965","","10.1212/WNL.0b013e3181aa52d3"
"19949165","Safety and tolerability of donepezil in mild cognitive impairment: open-label extension study","Doody RS, Ferris S, Salloway S, Yijun Sun, Goldman R, Yikang Xu, Gao J, Murthy AK.","Am J Alzheimers Dis Other Demen. 2010 Mar;25(2):155-9. doi: 10.1177/1533317509352334. Epub 2009 Nov 30.","Doody RS","Am J Alzheimers Dis Other Demen","2010","2009/12/02","","","10.1177/1533317509352334"
"25297016","Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial","Wilkinson D, Windfeld K, Colding-Jørgensen E.","Lancet Neurol. 2014 Nov;13(11):1092-1099. doi: 10.1016/S1474-4422(14)70198-X. Epub 2014 Oct 5.","Wilkinson D","Lancet Neurol","2014","2014/10/10","","","10.1016/S1474-4422(14)70198-X"
"12757558","Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden","Feldman H, Gauthier S, Hecker J, Vellas B, Emir B, Mastey V, Subbiah P; Donepezil MSAD Study Investigators Group.","J Am Geriatr Soc. 2003 Jun;51(6):737-44. doi: 10.1046/j.1365-2389.2003.51260.x.","Feldman H","J Am Geriatr Soc","2003","2003/05/22","","","10.1046/j.1365-2389.2003.51260.x"
"22500712","Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: a randomized, double-blind and parallel-controlled trial","Miao YC, Tian JZ, Shi J, Mao M.","Zhong Xi Yi Jie He Xue Bao. 2012 Apr;10(4):390-7. doi: 10.3736/jcim20120407.","Miao YC","Zhong Xi Yi Jie He Xue Bao","2012","2012/04/17","","","10.3736/jcim20120407"
"26967214","Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study","Florian H, Meier A, Gauthier S, Lipschitz S, Lin Y, Tang Q, Othman AA, Robieson WZ, Gault LM.","J Alzheimers Dis. 2016;51(4):1237-47. doi: 10.3233/JAD-150978.","Florian H","J Alzheimers Dis","2016","2016/03/12","","","10.3233/JAD-150978"
"11255446","Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease","Doody RS, Geldmacher DS, Gordon B, Perdomo CA, Pratt RD; Donepezil Study Group.","Arch Neurol. 2001 Mar;58(3):427-33. doi: 10.1001/archneur.58.3.427.","Doody RS","Arch Neurol","2001","2001/03/20","","","10.1001/archneur.58.3.427"
"20678673","Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study","Farlow MR, Salloway S, Tariot PN, Yardley J, Moline ML, Wang Q, Brand-Schieber E, Zou H, Hsu T, Satlin A.","Clin Ther. 2010 Jul;32(7):1234-51. doi: 10.1016/j.clinthera.2010.06.019.","Farlow MR","Clin Ther","2010","2010/08/04","PMC3068609","NIHMS238683","10.1016/j.clinthera.2010.06.019"
"27780331","Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer's Disease","Cavedo E, Dubois B, Colliot O, Lista S, Croisile B, Tisserand GL, Touchon J, Bonafe A, Ousset PJ, Rouaud O, Ricolfi F, Vighetto A, Pasquier F, Galluzzi S, Delmaire C, Ceccaldi M, Girard N, Lehericy S, Duveau F, Chupin M, Sarazin M, Dormont D, Hampel H; Hippocampus Study Group.","J Clin Psychiatry. 2016 Dec;77(12):e1631-e1638. doi: 10.4088/JCP.15m10413.","Cavedo E","J Clin Psychiatry","2016","2016/10/26","","","10.4088/JCP.15m10413"
"16626752","Effects of donepezil on memory and cognition in multiple sclerosis","Christodoulou C, Melville P, Scherl WF, Macallister WS, Elkins LE, Krupp LB.","J Neurol Sci. 2006 Jun 15;245(1-2):127-36. doi: 10.1016/j.jns.2005.08.021. Epub 2006 Apr 19.","Christodoulou C","J Neurol Sci","2006","2006/04/22","","","10.1016/j.jns.2005.08.021"
"12457078","An economic evaluation of donepezil in mild to moderate Alzheimer's disease: results of a 1-year, double-blind, randomized trial","Wimo A, Winblad B, Engedal K, Soininen H, Verhey F, Waldemar G, Wetterholm AL, Mastey V, Haglund A, Zhang R, Miceli R, Chin W, Subbiah P; Donepezil Nordic Study Group.","Dement Geriatr Cogn Disord. 2003;15(1):44-54. doi: 10.1159/000066669.","Wimo A","Dement Geriatr Cogn Disord","2003","2002/11/29","","","10.1159/000066669"
"10634454","Donepezil therapy in clinical practice: a randomized crossover study","Greenberg SM, Tennis MK, Brown LB, Gomez-Isla T, Hayden DL, Schoenfeld DA, Walsh KL, Corwin C, Daffner KR, Friedman P, Meadows ME, Sperling RA, Growdon JH.","Arch Neurol. 2000 Jan;57(1):94-9. doi: 10.1001/archneur.57.1.94.","Greenberg SM","Arch Neurol","2000","2000/01/14","","","10.1001/archneur.57.1.94"
"18672400","Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial","Lannfelt L, Blennow K, Zetterberg H, Batsman S, Ames D, Harrison J, Masters CL, Targum S, Bush AI, Murdoch R, Wilson J, Ritchie CW; PBT2-201-EURO study group.","Lancet Neurol. 2008 Sep;7(9):779-86. doi: 10.1016/S1474-4422(08)70167-4. Epub 2008 Jul 30.","Lannfelt L","Lancet Neurol","2008","2008/08/02","","","10.1016/S1474-4422(08)70167-4"
"30636738","Open-Label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer's Disease","Frölich L, Atri A, Ballard C, Tariot PN, Molinuevo JL, Boneva N, Geist MA, Raket LL, Cummings JL.","J Alzheimers Dis. 2019;67(1):303-313. doi: 10.3233/JAD-180595.","Frölich L","J Alzheimers Dis","2019","2019/01/15","","","10.3233/JAD-180595"
"29622037","A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer's disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil","Fullerton T, Binneman B, David W, Delnomdedieu M, Kupiec J, Lockwood P, Mancuso J, Miceli J, Bell J.","Alzheimers Res Ther. 2018 Apr 5;10(1):38. doi: 10.1186/s13195-018-0368-9.","Fullerton T","Alzheimers Res Ther","2018","2018/04/07","PMC5887246","","10.1186/s13195-018-0368-9"
"16767418","Effects of donepezil on cortical metabolic response to activation during (18)FDG-PET in Alzheimer's disease: a double-blind cross-over trial","Teipel SJ, Drzezga A, Bartenstein P, Möller HJ, Schwaiger M, Hampel H.","Psychopharmacology (Berl). 2006 Jul;187(1):86-94. doi: 10.1007/s00213-006-0408-1. Epub 2006 Jun 1.","Teipel SJ","Psychopharmacology (Berl)","2006","2006/06/13","","","10.1007/s00213-006-0408-1"
"12670060","Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease","Gauthier S, Feldman H, Hecker J, Vellas B, Ames D, Subbiah P, Whalen E, Emir B; Donepezil MSAD Study Investigators Group.","Int Psychogeriatr. 2002 Dec;14(4):389-404. doi: 10.1017/s104161020200858x.","Gauthier S","Int Psychogeriatr","2002","2003/04/03","","","10.1017/s104161020200858x"
"19838862","A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease","Akhondzadeh S, Shafiee Sabet M, Harirchian MH, Togha M, Cheraghmakani H, Razeghi S, Hejazi SS, Yousefi MH, Alimardani R, Jamshidi A, Rezazadeh SA, Yousefi A, Zare F, Moradi A, Vossoughi A.","Psychopharmacology (Berl). 2010 Jan;207(4):637-43. doi: 10.1007/s00213-009-1706-1. Epub 2009 Oct 20.","Akhondzadeh S","Psychopharmacology (Berl)","2010","2009/10/20","","","10.1007/s00213-009-1706-1"
"15277611","The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease","Holmes C, Wilkinson D, Dean C, Vethanayagam S, Olivieri S, Langley A, Pandita-Gunawardena ND, Hogg F, Clare C, Damms J.","Neurology. 2004 Jul 27;63(2):214-9. doi: 10.1212/01.wnl.0000129990.32253.7b.","Holmes C","Neurology","2004","2004/07/28","","","10.1212/01.wnl.0000129990.32253.7b"
"18288936","Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial","Porsteinsson AP, Grossberg GT, Mintzer J, Olin JT; Memantine MEM-MD-12 Study Group.","Curr Alzheimer Res. 2008 Feb;5(1):83-9. doi: 10.2174/156720508783884576.","Porsteinsson AP","Curr Alzheimer Res","2008","2008/02/22","","","10.2174/156720508783884576"
"18042476","Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients","Sun Y, Lu CJ, Chien KL, Chen ST, Chen RC.","Clin Ther. 2007 Oct;29(10):2204-14. doi: 10.1016/j.clinthera.2007.10.012.","Sun Y","Clin Ther","2007","2007/11/29","","","10.1016/j.clinthera.2007.10.012"
"30037778","Donepezil Treatment in Patients With Depression and Cognitive Impairment on Stable Antidepressant Treatment: A Randomized Controlled Trial","Devanand DP, Pelton GH, D'Antonio K, Ciarleglio A, Scodes J, Andrews H, Lunsford J, Beyer JL, Petrella JR, Sneed J, Ciovacco M, Doraiswamy PM.","Am J Geriatr Psychiatry. 2018 Oct;26(10):1050-1060. doi: 10.1016/j.jagp.2018.05.008. Epub 2018 Jun 28.","Devanand DP","Am J Geriatr Psychiatry","2018","2018/07/25","PMC6396676","NIHMS1013581","10.1016/j.jagp.2018.05.008"
"15496222","Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses","Okereke CS, Kirby L, Kumar D, Cullen EI, Pratt RD, Hahne WA.","Br J Clin Pharmacol. 2004 Nov;58 Suppl 1(Suppl 1):41-9. doi: 10.1111/j.1365-2125.2004.01799.x.","Okereke CS","Br J Clin Pharmacol","2004","2004/10/22","PMC1884553","","10.1111/j.1365-2125.2004.01799.x"
"32508323","Volume Analysis of Brain Cognitive Areas in Alzheimer's Disease: Interim 3-Year Results from the ASCOMALVA Trial","Traini E, Carotenuto A, Fasanaro AM, Amenta F.","J Alzheimers Dis. 2020;76(1):317-329. doi: 10.3233/JAD-190623.","Traini E","J Alzheimers Dis","2020","2020/06/09","PMC7369051","","10.3233/JAD-190623"
"24880524","[Effects of a neuropsychology program based on mindfulness on Alzheimer's disease: randomized double-blind clinical study]","Quintana Hernández DJ, Miró Barrachina MT, Ibáñez Fernández I, del Pino AS, García Rodríguez Jr, Hernández JR.","Rev Esp Geriatr Gerontol. 2014 Jul-Aug;49(4):165-72. doi: 10.1016/j.regg.2014.03.002. Epub 2014 May 28.","Quintana Hernández DJ","Rev Esp Geriatr Gerontol","2014","2014/06/02","","","10.1016/j.regg.2014.03.002"
"19176895","Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial","Doody RS, Ferris SH, Salloway S, Sun Y, Goldman R, Watkins WE, Xu Y, Murthy AK.","Neurology. 2009 May 5;72(18):1555-61. doi: 10.1212/01.wnl.0000344650.95823.03. Epub 2009 Jan 28.","Doody RS","Neurology","2009","2009/01/30","","","10.1212/01.wnl.0000344650.95823.03"
"16816014","Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders","Cummings JL, McRae T, Zhang R; Donepezil-Sertraline Study Group.","Am J Geriatr Psychiatry. 2006 Jul;14(7):605-12. doi: 10.1097/01.JGP.0000221293.91312.d3.","Cummings JL","Am J Geriatr Psychiatry","2006","2006/07/04","","","10.1097/01.JGP.0000221293.91312.d3"
"22930699","Subgroup analysis of US and non-US patients in a global study of high-dose donepezil (23 mg) in moderate and severe Alzheimer's disease","Salloway S, Mintzer J, Cummings JL, Geldmacher D, Sun Y, Yardley J, Mackell J.","Am J Alzheimers Dis Other Demen. 2012 Sep;27(6):421-32. doi: 10.1177/1533317512454708.","Salloway S","Am J Alzheimers Dis Other Demen","2012","2012/08/30","","","10.1177/1533317512454708"
"19786776","Effectiveness of donepezil in reducing clinical worsening in patients with mild-to-moderate alzheimer's disease","Wilkinson D, Schindler R, Schwam E, Waldemar G, Jones RW, Gauthier S, Lopez OL, Cummings J, Xu Y, Feldman HH.","Dement Geriatr Cogn Disord. 2009;28(3):244-51. doi: 10.1159/000241877. Epub 2009 Sep 25.","Wilkinson D","Dement Geriatr Cogn Disord","2009","2009/09/30","PMC3202931","","10.1159/000241877"
"34164794","Safety and Pharmacokinetics of HTL0018318, a Novel M(1) Receptor Agonist, Given in Combination with Donepezil at Steady State: A Randomized Trial in Healthy Elderly Subjects","Bakker C, van der Aart J, Labots G, Liptrot J, Cross DM, Klaassen ES, Dickinson S, Tasker T, Groeneveld GJ.","Drugs R D. 2021 Sep;21(3):295-304. doi: 10.1007/s40268-021-00352-5. Epub 2021 Jun 23.","Bakker C","Drugs R D","2021","2021/06/24","PMC8363684","","10.1007/s40268-021-00352-5"
"12611746","Donepezil HCl (E2020) maintains functional brain activity in patients with Alzheimer disease: results of a 24-week, double-blind, placebo-controlled study","Tune L, Tiseo PJ, Ieni J, Perdomo C, Pratt RD, Votaw JR, Jewart RD, Hoffman JM.","Am J Geriatr Psychiatry. 2003 Mar-Apr;11(2):169-77.","Tune L","Am J Geriatr Psychiatry","2003","2003/03/04","","",""
"16062097","Efficacy and tolerability of low-dose donepezil in schizophrenia","Erickson SK, Schwarzkopf SB, Palumbo D, Badgley-Fleeman J, Smirnow AM, Light GA.","Clin Neuropharmacol. 2005 Jul-Aug;28(4):179-84. doi: 10.1097/01.wnf.0000173714.61744.e6.","Erickson SK","Clin Neuropharmacol","2005","2005/08/03","","","10.1097/01.wnf.0000173714.61744.e6"
"21495523","Donepezil significantly improves abilities in daily lives of female Down syndrome patients with severe cognitive impairment: a 24-week randomized, double-blind, placebo-controlled trial","Kondoh T, Kanno A, Itoh H, Nakashima M, Honda R, Kojima M, Noguchi M, Nakane H, Nozaki H, Sasaki H, Nagai T, Kosaki R, Kakee N, Okuyama T, Fukuda M, Ikeda M, Shibata Y, Moriuchi H.","Int J Psychiatry Med. 2011;41(1):71-89. doi: 10.2190/PM.41.1.g.","Kondoh T","Int J Psychiatry Med","2011","2011/04/19","","","10.2190/PM.41.1.g"
"15326237","Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial","Salloway S, Ferris S, Kluger A, Goldman R, Griesing T, Kumar D, Richardson S; Donepezil 401 Study Group.","Neurology. 2004 Aug 24;63(4):651-7. doi: 10.1212/01.wnl.0000134664.80320.92.","Salloway S","Neurology","2004","2004/08/25","","","10.1212/01.wnl.0000134664.80320.92"
"16192723","Donepezil in vascular dementia: combined analysis of two large-scale clinical trials","Román GC, Wilkinson DG, Doody RS, Black SE, Salloway SP, Schindler RJ.","Dement Geriatr Cogn Disord. 2005;20(6):338-44. doi: 10.1159/000088494. Epub 2005 Sep 23.","Román GC","Dement Geriatr Cogn Disord","2005","2005/09/30","","","10.1159/000088494"
"12567159","Beneficial effect of donepezil augmentation for the management of comorbid schizophrenia and dementia","Stryjer R, Strous RD, Bar F, Werber E, Shaked G, Buhiri Y, Kotler M, Weizman A, Rabey JM.","Clin Neuropharmacol. 2003 Jan-Feb;26(1):12-7. doi: 10.1097/00002826-200301000-00004.","Stryjer R","Clin Neuropharmacol","2003","2003/02/05","","","10.1097/00002826-200301000-00004"
"19001543","Effects of donepezil on cortical activation in mild cognitive impairment: a pilot double-blind placebo-controlled trial using functional MR imaging","Petrella JR, Prince SE, Krishnan S, Husn H, Kelley L, Doraiswamy PM.","AJNR Am J Neuroradiol. 2009 Feb;30(2):411-6. doi: 10.3174/ajnr.A1359. Epub 2008 Nov 11.","Petrella JR","AJNR Am J Neuroradiol","2009","2008/11/13","PMC7051379","","10.3174/ajnr.A1359"
"20395618","Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size","Román GC, Salloway S, Black SE, Royall DR, Decarli C, Weiner MW, Moline M, Kumar D, Schindler R, Posner H.","Stroke. 2010 Jun;41(6):1213-21. doi: 10.1161/STROKEAHA.109.570077. Epub 2010 Apr 15.","Román GC","Stroke","2010","2010/04/17","PMC2954887","NIHMS232062","10.1161/STROKEAHA.109.570077"
"20880294","Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease","Parnetti L, Chiasserini D, Andreasson U, Ohlson M, Hüls C, Zetterberg H, Minthon L, Wallin AK, Andreasen N, Talesa VN, Blennow K.","Acta Neurol Scand. 2011 Aug;124(2):122-9. doi: 10.1111/j.1600-0404.2010.01435.x. Epub 2010 Sep 29.","Parnetti L","Acta Neurol Scand","2011","2010/10/01","","","10.1111/j.1600-0404.2010.01435.x"
"12939421","Donepezil in vascular dementia: a randomized, placebo-controlled study","Wilkinson D, Doody R, Helme R, Taubman K, Mintzer J, Kertesz A, Pratt RD; Donepezil 308 Study Group.","Neurology. 2003 Aug 26;61(4):479-86. doi: 10.1212/01.wnl.0000078943.50032.fc.","Wilkinson D","Neurology","2003","2003/08/27","","","10.1212/01.wnl.0000078943.50032.fc"
"17132970","Cognitive response to memantine in moderate to severe Alzheimer disease patients already receiving donepezil: an exploratory reanalysis","Schmitt FA, van Dyck CH, Wichems CH, Olin JT; Memantine MEM-MD-02 Study Group.","Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):255-62. doi: 10.1097/01.wad.0000213860.35355.d4.","Schmitt FA","Alzheimer Dis Assoc Disord","2006","2006/11/30","","","10.1097/01.wad.0000213860.35355.d4"
"16191240","Patient populations in clinical studies of donepezil in vascular dementia","Pratt RD.","Int Psychogeriatr. 2003;15 Suppl 1:195-200. doi: 10.1017/S1041610203009190.","Pratt RD","Int Psychogeriatr","2003","2005/09/30","","","10.1017/S1041610203009190"
"20200346","Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe","Feldman HH, Doody RS, Kivipelto M, Sparks DL, Waters DD, Jones RW, Schwam E, Schindler R, Hey-Hadavi J, DeMicco DA, Breazna A; LEADe Investigators.","Neurology. 2010 Mar 23;74(12):956-64. doi: 10.1212/WNL.0b013e3181d6476a. Epub 2010 Mar 3.","Feldman HH","Neurology","2010","2010/03/05","","","10.1212/WNL.0b013e3181d6476a"
"36709275","Efficacy and safety of the novel GlyT1 inhibitor BI 425809 in Alzheimer's dementia: a randomized controlled trial","Wunderlich G, Blahova Z, Garcia M, Jessen F.","Alzheimers Res Ther. 2023 Jan 28;15(1):24. doi: 10.1186/s13195-023-01163-3.","Wunderlich G","Alzheimers Res Ther","2023","2023/01/28","PMC9883916","","10.1186/s13195-023-01163-3"
"17582225","Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms","Freund-Levi Y, Basun H, Cederholm T, Faxén-Irving G, Garlind A, Grut M, Vedin I, Palmblad J, Wahlund LO, Eriksdotter-Jönhagen M.","Int J Geriatr Psychiatry. 2008 Feb;23(2):161-9. doi: 10.1002/gps.1857.","Freund-Levi Y","Int J Geriatr Psychiatry","2008","2007/06/22","","","10.1002/gps.1857"
"18541979","Effects of donepezil on verbal memory after semantic processing in healthy older adults","FitzGerald DB, Crucian GP, Mielke JB, Shenal BV, Burks D, Womack KB, Ghacibeh G, Drago V, Foster PS, Valenstein E, Heilman KM.","Cogn Behav Neurol. 2008 Jun;21(2):57-64. doi: 10.1097/WNN.0b013e3181799df1.","FitzGerald DB","Cogn Behav Neurol","2008","2008/06/11","","","10.1097/WNN.0b013e3181799df1"
"26876309","Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal Alzheimer's disease","Teipel SJ, Cavedo E, Grothe MJ, Lista S, Galluzzi S, Colliot O, Chupin M, Bakardjian H, Dormont D, Dubois B, Hampel H; Hippocampus Study Group.","Neuropharmacology. 2016 Sep;108:128-35. doi: 10.1016/j.neuropharm.2016.02.005. Epub 2016 Feb 10.","Teipel SJ","Neuropharmacology","2016","2016/02/16","","","10.1016/j.neuropharm.2016.02.005"
"14734594","Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial","Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I; Memantine Study Group.","JAMA. 2004 Jan 21;291(3):317-24. doi: 10.1001/jama.291.3.317.","Tariot PN","JAMA","2004","2004/01/22","","","10.1001/jama.291.3.317"
"12970516","Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial","Black S, Román GC, Geldmacher DS, Salloway S, Hecker J, Burns A, Perdomo C, Kumar D, Pratt R; Donepezil 307 Vascular Dementia Study Group.","Stroke. 2003 Oct;34(10):2323-30. doi: 10.1161/01.STR.0000091396.95360.E1. Epub 2003 Sep 11.","Black S","Stroke","2003","2003/09/13","","","10.1161/01.STR.0000091396.95360.E1"
"24314887","Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's Disease Study 2","Flynn Longmire CV, Drye LT, Frangakis CE, Martin BK, Meinert CL, Mintzer JE, Munro CA, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG; DIADS-2 Research Group.","Am J Geriatr Psychiatry. 2014 Jan;22(1):14-24. doi: 10.1016/j.jagp.2013.02.014.","Flynn Longmire CV","Am J Geriatr Psychiatry","2014","2013/12/10","PMC3910508","NIHMS540846","10.1016/j.jagp.2013.02.014"
"16670247","A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil","van Dyck CH, Schmitt FA, Olin JT; Memantine MEM-MD-02 Study Group.","Am J Geriatr Psychiatry. 2006 May;14(5):428-37. doi: 10.1097/01.JGP.0000203151.17311.38.","van Dyck CH","Am J Geriatr Psychiatry","2006","2006/05/04","","","10.1097/01.JGP.0000203151.17311.38"
"14520164","The effects of a cholinesterase inhibitor are prominent in patients with fluctuating cognition: a part 3 study of the main mechanism of cholinesterase inhibitors in dementia","Onofrj M, Thomas A, Iacono D, Luciano AL, Di Iorio A.","Clin Neuropharmacol. 2003 Sep-Oct;26(5):239-51. doi: 10.1097/00002826-200309000-00008.","Onofrj M","Clin Neuropharmacol","2003","2003/10/02","","","10.1097/00002826-200309000-00008"
"16928344","Donepezil in patients with severe Alzheimer's disease: double-blind parallel-group, placebo controlled study","Marder K.","Curr Neurol Neurosci Rep. 2006 Sep;6(5):364-3. doi: 10.1007/s11910-996-0015-x.","Marder K","Curr Neurol Neurosci Rep","2006","2006/08/25","","","10.1007/s11910-996-0015-x"
"15832031","Do vascular lesions and related risk factors influence responsiveness to donepezil chloride in patients with Alzheimer's disease?","Fukui T, Taguchi S.","Dement Geriatr Cogn Disord. 2005;20(1):15-24. doi: 10.1159/000085069. Epub 2005 Apr 12.","Fukui T","Dement Geriatr Cogn Disord","2005","2005/04/16","","","10.1159/000085069"
"15107192","Neuropsychological test performance in healthy volunteers before and after donepezil administration","Beglinger LJ, Gaydos BL, Kareken DA, Tangphao-Daniels O, Siemers ER, Mohs RC.","J Psychopharmacol. 2004 Mar;18(1):102-8. doi: 10.1177/0269881104040248.","Beglinger LJ","J Psychopharmacol","2004","2004/04/27","","","10.1177/0269881104040248"
"12837144","Donepezil use for advanced Alzheimer's disease--a case study from a long-term care facility","Tariot PN, Jakimovich L.","J Am Med Dir Assoc. 2003 Jul-Aug;4(4):216-9. doi: 10.1097/01.JAM.0000075830.81747.72.","Tariot PN","J Am Med Dir Assoc","2003","2003/07/03","","","10.1097/01.JAM.0000075830.81747.72"
"11502918","A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD","Winblad B, Engedal K, Soininen H, Verhey F, Waldemar G, Wimo A, Wetterholm AL, Zhang R, Haglund A, Subbiah P; Donepezil Nordic Study Group.","Neurology. 2001 Aug 14;57(3):489-95. doi: 10.1212/wnl.57.3.489.","Winblad B","Neurology","2001","2001/08/15","","","10.1212/wnl.57.3.489"
"16478570","Donepezil for negative signs in elderly patients with schizophrenia: an add-on, double-blind, crossover, placebo-controlled study","Mazeh D, Zemishlani H, Barak Y, Mirecki I, Paleacu D.","Int Psychogeriatr. 2006 Sep;18(3):429-36. doi: 10.1017/S1041610205003017. Epub 2006 Feb 15.","Mazeh D","Int Psychogeriatr","2006","2006/02/16","","","10.1017/S1041610205003017"
"25024314","A randomized study of H3 antagonist ABT-288 in mild-to-moderate Alzheimer's dementia","Haig GM, Pritchett Y, Meier A, Othman AA, Hall C, Gault LM, Lenz RA.","J Alzheimers Dis. 2014;42(3):959-71. doi: 10.3233/JAD-140291.","Haig GM","J Alzheimers Dis","2014","2014/07/16","","","10.3233/JAD-140291"
"23032478","Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease","Munro CA, Longmire CF, Drye LT, Martin BK, Frangakis CE, Meinert CL, Mintzer JE, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG; Depression in Alzheimer’s Disease Study–2 Research Group.","Am J Geriatr Psychiatry. 2012 Dec;20(12):1036-44. doi: 10.1097/JGP.0b013e31826ce4c5.","Munro CA","Am J Geriatr Psychiatry","2012","2012/10/04","PMC3508666","NIHMS421954","10.1097/JGP.0b013e31826ce4c5"
"26639952","Mindfulness in the Maintenance of Cognitive Capacities in Alzheimer's Disease: A Randomized Clinical Trial","Quintana-Hernández DJ, Miró-Barrachina MT, Ibáñez-Fernández IJ, Pino AS, Quintana-Montesdeoca MP, Rodríguez-de Vera B, Morales-Casanova D, Pérez-Vieitez Mdel C, Rodríguez-García J, Bravo-Caraduje N.","J Alzheimers Dis. 2016;50(1):217-32. doi: 10.3233/JAD-143009.","Quintana-Hernández DJ","J Alzheimers Dis","2016","2015/12/08","","","10.3233/JAD-143009"
"26076022","Cognitive Improvement during Treatment for Mild Alzheimer's Disease with a Chinese Herbal Formula: A Randomized Controlled Trial","Zhang Y, Lin C, Zhang L, Cui Y, Gu Y, Guo J, Wu D, Li Q, Song W.","PLoS One. 2015 Jun 15;10(6):e0130353. doi: 10.1371/journal.pone.0130353. eCollection 2015.","Zhang Y","PLoS One","2015","2015/06/16","PMC4468068","","10.1371/journal.pone.0130353"
"19262966","Methodological improvements in quantifying cognitive change in clinical trials: an example with single-dose administration of donepezil","Pietrzak RH, Maruff P, Snyder PJ.","J Nutr Health Aging. 2009 Mar;13(3):268-73. doi: 10.1007/s12603-009-0071-4.","Pietrzak RH","J Nutr Health Aging","2009","2009/03/06","","","10.1007/s12603-009-0071-4"
"10216789","Is donepezil effective for treating Alzheimer's disease?","Steele LS, Glazier RH.","Can Fam Physician. 1999 Apr;45:917-9.","Steele LS","Can Fam Physician","1999","1999/04/27","PMC2328349","",""
"18230972","Treatment of a whole population sample of Alzheimer's disease with donepezil over a 4-year period: lessons learned","Lyle S, Grizzell M, Willmott S, Benbow S, Clark M, Jolley D.","Dement Geriatr Cogn Disord. 2008;25(3):226-31. doi: 10.1159/000114450. Epub 2008 Jan 30.","Lyle S","Dement Geriatr Cogn Disord","2008","2008/01/31","","","10.1159/000114450"
"12417358","Patient populations in clinical trials of the efficacy and tolerability of donepezil in patients with vascular dementia","Pratt RD.","J Neurol Sci. 2002 Nov 15;203-204:57-65. doi: 10.1016/s0022-510x(02)00266-6.","Pratt RD","J Neurol Sci","2002","2002/11/06","","","10.1016/s0022-510x(02)00266-6"
"17452579","Quetiapine for agitation or psychosis in patients with dementia and parkinsonism","Kurlan R, Cummings J, Raman R, Thal L; Alzheimer's Disease Cooperative Study Group.","Neurology. 2007 Apr 24;68(17):1356-63. doi: 10.1212/01.wnl.0000260060.60870.89.","Kurlan R","Neurology","2007","2007/04/25","","","10.1212/01.wnl.0000260060.60870.89"
"15852437","Switching from donepezil to galantamine: a double-blind study of two wash-out periods","Wilkinson DG, Howe I.","Int J Geriatr Psychiatry. 2005 May;20(5):489-91. doi: 10.1002/gps.1301.","Wilkinson DG","Int J Geriatr Psychiatry","2005","2005/04/27","","","10.1002/gps.1301"
"18317244","Effects of galantamine on measures of attention: results from 2 clinical trials in Alzheimer disease patients with comparisons to donepezil","Galvin JE, Cornblatt B, Newhouse P, Ancoli-Israel S, Wesnes K, Williamson D, Zhu Y, Sorra K, Amatniek J.","Alzheimer Dis Assoc Disord. 2008 Jan-Mar;22(1):30-8. doi: 10.1097/WAD.0b013e3181630b81.","Galvin JE","Alzheimer Dis Assoc Disord","2008","2008/03/05","","","10.1097/WAD.0b013e3181630b81"
"11001599","Orbital and dorsolateral frontal perfusion defect associated with behavioral response to cholinesterase inhibitor therapy in Alzheimer's disease","Mega MS, Dinov ID, Lee L, O'Connor SM, Masterman DM, Wilen B, Mishkin F, Toga AW, Cummings JL.","J Neuropsychiatry Clin Neurosci. 2000 Spring;12(2):209-18. doi: 10.1176/jnp.12.2.209.","Mega MS","J Neuropsychiatry Clin Neurosci","2000","2000/09/23","","","10.1176/jnp.12.2.209"
"14718699","Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study","Reines SA, Block GA, Morris JC, Liu G, Nessly ML, Lines CR, Norman BA, Baranak CC; Rofecoxib Protocol 091 Study Group.","Neurology. 2004 Jan 13;62(1):66-71. doi: 10.1212/wnl.62.1.66.","Reines SA","Neurology","2004","2004/01/14","","","10.1212/wnl.62.1.66"
"19571727","A brief instrument to assess treatment response in the patient with advanced Alzheimer disease","Schmitt FA, Saxton JA, Xu Y, McRae T, Sun Y, Richardson S, Li H.","Alzheimer Dis Assoc Disord. 2009 Oct-Dec;23(4):377-83. doi: 10.1097/WAD.0b013e3181ac9cc1.","Schmitt FA","Alzheimer Dis Assoc Disord","2009","2009/07/03","","","10.1097/WAD.0b013e3181ac9cc1"
"21555634","Test-retest reliability of memory task functional magnetic resonance imaging in Alzheimer disease clinical trials","Atri A, O'Brien JL, Sreenivasan A, Rastegar S, Salisbury S, DeLuca AN, O'Keefe KM, LaViolette PS, Rentz DM, Locascio JJ, Sperling RA.","Arch Neurol. 2011 May;68(5):599-606. doi: 10.1001/archneurol.2011.94.","Atri A","Arch Neurol","2011","2011/05/11","PMC3291175","NIHMS358173","10.1001/archneurol.2011.94"
"23694947","Ventricular enlargement and its clinical correlates in the imaging cohort from the ADCS MCI donepezil/vitamin E study","Apostolova LG, Babakchanian S, Hwang KS, Green AE, Zlatev D, Chou YY, DeCarli C, Jack CR Jr, Petersen RC, Aisen PS, Cummings JL, Toga AW, Thompson PM.","Alzheimer Dis Assoc Disord. 2013 Apr-Jun;27(2):174-81. doi: 10.1097/WAD.0b013e3182677b3d.","Apostolova LG","Alzheimer Dis Assoc Disord","2013","2013/05/23","PMC3662002","NIHMS397817","10.1097/WAD.0b013e3182677b3d"
"14617718","A randomised placebo controlled study to assess the effects of cholinergic treatment on muscarinic receptors in Alzheimer's disease","Kemp PM, Holmes C, Hoffmann S, Wilkinson S, Zivanovic M, Thom J, Bolt L, Fleming J, Wilkinson DG.","J Neurol Neurosurg Psychiatry. 2003 Nov;74(11):1567-70. doi: 10.1136/jnnp.74.11.1567.","Kemp PM","J Neurol Neurosurg Psychiatry","2003","2003/11/18","PMC1738233","","10.1136/jnnp.74.11.1567"
"21258153","Effects of AZD3480 on cognition in patients with mild-to-moderate Alzheimer's disease: a phase IIb dose-finding study","Frölich L, Ashwood T, Nilsson J, Eckerwall G; Sirocco Investigators.","J Alzheimers Dis. 2011;24(2):363-74. doi: 10.3233/JAD-2011-101554.","Frölich L","J Alzheimers Dis","2011","2011/01/25","","","10.3233/JAD-2011-101554"
"14561111","Effects of donepezil on cognitive functioning in Down syndrome","Johnson N, Fahey C, Chicoine B, Chong G, Gitelman D.","Am J Ment Retard. 2003 Nov;108(6):367-72. doi: 10.1352/0895-8017(2003)108<367:EODOCF>2.0.CO;2.","Johnson N","Am J Ment Retard","2003","2003/10/17","","","10.1352/0895-8017(2003)108<367:EODOCF>2.0.CO;2"
"29318278","Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials","Atri A, Frölich L, Ballard C, Tariot PN, Molinuevo JL, Boneva N, Windfeld K, Raket LL, Cummings JL.","JAMA. 2018 Jan 9;319(2):130-142. doi: 10.1001/jama.2017.20373.","Atri A","JAMA","2018","2018/01/11","PMC5833662","","10.1001/jama.2017.20373"
"18229874","Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease","Waldemar G, Hyvärinen M, Josiassen MK, Kørner A, Lehto H, Wetterberg P.","Int J Geriatr Psychiatry. 2008 Sep;23(9):979-81. doi: 10.1002/gps.1979.","Waldemar G","Int J Geriatr Psychiatry","2008","2008/01/31","","","10.1002/gps.1979"
"18825439","Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia","van Straaten EC, Harvey D, Scheltens P, Barkhof F, Petersen RC, Thal LJ, Jack CR Jr, DeCarli C; Alzheimer's Disease Cooperative Study Group.","J Neurol. 2008 Sep;255(9):1302-8. doi: 10.1007/s00415-008-0874-y. Epub 2008 Sep 25.","van Straaten EC","J Neurol","2008","2008/10/01","PMC2879405","NIHMS204576","10.1007/s00415-008-0874-y"
"11502917","A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients","Mohs RC, Doody RS, Morris JC, Ieni JR, Rogers SL, Perdomo CA, Pratt RD; ""312"" Study Group.","Neurology. 2001 Aug 14;57(3):481-8. doi: 10.1212/wnl.57.3.481.","Mohs RC","Neurology","2001","2001/08/15","","","10.1212/wnl.57.3.481"
"21592048","Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies","Harrington C, Sawchak S, Chiang C, Davies J, Donovan C, Saunders AM, Irizarry M, Jeter B, Zvartau-Hind M, van Dyck CH, Gold M.","Curr Alzheimer Res. 2011 Aug;8(5):592-606. doi: 10.2174/156720511796391935.","Harrington C","Curr Alzheimer Res","2011","2011/05/20","","","10.2174/156720511796391935"
"23436269","Population pharmacokinetic modeling of sertraline treatment in patients with Alzheimer disease: the DIADS-2 study","Li CH, Pollock BG, Lyketsos CG, Vaidya V, Drye LT, Kirshner M, Sorisio D, Bies RR; DIADS-2 Research Group.","J Clin Pharmacol. 2013 Feb;53(2):234-9. doi: 10.1177/0091270012445793. Epub 2013 Jan 24.","Li CH","J Clin Pharmacol","2013","2013/02/26","PMC3604147","NIHMS426162","10.1177/0091270012445793"
"25316430","Management of cognitive determinants in senile dementia of Alzheimer's type: therapeutic potential of a novel polyherbal drug product","Sadhu A, Upadhyay P, Agrawal A, Ilango K, Karmakar D, Singh GP, Dubey GP.","Clin Drug Investig. 2014 Dec;34(12):857-69. doi: 10.1007/s40261-014-0235-9.","Sadhu A","Clin Drug Investig","2014","2014/10/16","","","10.1007/s40261-014-0235-9"
"17210817","Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia","DeCarli C, Frisoni GB, Clark CM, Harvey D, Grundman M, Petersen RC, Thal LJ, Jin S, Jack CR Jr, Scheltens P; Alzheimer's Disease Cooperative Study Group.","Arch Neurol. 2007 Jan;64(1):108-15. doi: 10.1001/archneur.64.1.108.","DeCarli C","Arch Neurol","2007","2007/01/11","","","10.1001/archneur.64.1.108"